title: Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture area.
authors.affiliation: Robert A. Taft Laboratories, National Institute for Occupational Safety and Health (MS-C23), 4676 Columbia Parkway, Cincinnati, OH 45226, USA. twc6@cdc.gov
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Connor
authors.forename: Roger W
authors.initials: RW
authors.lastname: Anderson
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Sessink
authors.forename: Susan M
authors.initials: SM
authors.lastname: Spivey
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects*; D004784:Environmental Monitoring; D004867:Equipment Design; D005472:Fluorouracil / Q000009:adverse effects*; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D007262:Infusions, Intravenous; D016273:Occupational Exposure / Q000517:prevention & control*; D010595:Pharmacists
chemical_list: D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D005472:Fluorouracil; D007069:Ifosfamide